Detalhe da pesquisa
1.
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
Blood
; 142(7): 621-628, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319432
2.
Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade.
Blood
; 142(16): 1359-1370, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339586
3.
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Blood
; 139(25): 3605-3616, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316328
4.
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.
Blood
; 140(25): 2697-2708, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700381
5.
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.
Blood
; 140(19): 2024-2036, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914220
6.
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
Blood
; 140(5): 419-437, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758074
7.
Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management.
Am J Hematol
; 99(3): 439-456, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38304959
8.
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Br J Haematol
; 202(3): 525-529, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217196
9.
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.
Br J Haematol
; 200(1): 54-63, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36120837
10.
Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy.
J Natl Compr Canc Netw
; 21(4): 373-382.e1, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015335
11.
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma.
Am J Hematol
; 98(11): 1751-1761, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668287
12.
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Br J Haematol
; 197(2): 212-222, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106754
13.
Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome.
Br J Dermatol
; 187(2): 234-243, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35194801
14.
Emerging drugs for the treatment of cutaneous T-cell lymphoma.
Expert Opin Emerg Drugs
; 27(1): 45-54, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235473
15.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(3): 285-308, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276674
16.
Letermovir and maribavir for pan-resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy.
J Clin Pharm Ther
; 47(5): 699-702, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35023177
17.
Aggressive T-cell lymphomas: 2021 Updates on diagnosis, risk stratification and management.
Am J Hematol
; 96(8): 1027-1046, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111312
18.
The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas.
Support Care Cancer
; 29(11): 6669-6679, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963457
19.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
J Natl Compr Canc Netw
; 18(11): 1460-1467, 2020 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152703
20.
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
J Natl Compr Canc Netw
; 18(5): 522-536, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380458